8 Federal Street, Billerica, MA 01821
+1 978 313 3900
2520 Meridian Parkway,
Research Triangle Park, Suite 200,
Durham, NC 27713
+1 919 544 3170
© 2000-2019. Parexel International Corporation.
8 Federal Street, Billerica, MA 01821
+1 978 313 3900
2520 Meridian Parkway,
Research Triangle Park, Suite 200,
Durham, NC 27713
+1 919 544 3170
© 2000-2019. Parexel International Corporation.
Flexibility is one of the most powerful tools in your trial design arsenal. That’s why Adaptive Trial Designs give you the opportunity to reduce risk of failure by factoring in analyses at key points so study design parameters like sample size, dosage, or patient selection can be adjusted accordingly.
In fact, a 2018 report we commissioned called The Innovation Imperative: The Future of Drug Development by The Economist Intelligence Unit (EIU) found that adaptive trial designs boost a new therapy’s likelihood of launch by 13% on average. That percentage climbs even higher in certain therapeutic areas – up to 32% for oncology. However, although this approach is encouraging, it’s still not widely used.
By implementing Adaptive Trial Designs you have the opportunity to carefully evaluate clinical data in real-time, so you can make informed decisions to change the direction of the study for a better chance of success. A well-designed and executed Adaptive Trial Design can:
More services we provide:
Learn how to evaluate interim data at pre-defined points and then adapt your study design parameters to optimize outcomes.
Visit our Preference Center to provide, view and edit your communication preferences, topics of interest, and contact information.
Drug Development Innovations that Work: Adaptive Trial Designs
View Now
Parexel’s Global Data Operations
Watch Now
Increasing Study Predictability with Parexel
Watch Now
Patient Recruitment in Asia
View Now
Crafting a genomics strategy early is key for successful oncology drug development
View Now
Global Data Operations Overview Brochure
View Now
Modifying Methods as seen in International Clinical Trials
View Now